SPRAY III (Sativex® for Pain Research in Advanced malignancY) is a clinical research study to determine if the investigational medication Sativex® (nabiximols) is effective in managing chronic cancer pain. An investigational medication is one that has not been approved yet by your country. Sativex® has been approved in Canada as an add-on treatment for pain in patients with advanced cancer.
Sativex® comes in the form of a mouth spray taken by spraying it in your mouth on the inside of your cheeks. More details on how to take this study medication will be provided to you if you decide to participate in the SPRAY III study.
If you are located outside the United States, please select a participating country below.